BOPCF
Price:
$0.9227
Market Cap:
$1.04B
BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. The company was incorporated in 2016 and is based in Exeter, the United Kingdom.
Industry
Asset Management
IPO Date
2018-08-21
Stock Exchange
OTC
Ticker
BOPCF
According to BioPharma Credit PLC’s latest financial reports and current stock price. The company's current ROE is 10.14%. This represents a change of 122.26% compared to the average of 4.56% of the last 4 quarters.
The mean historical ROE of BioPharma Credit PLC over the last ten years is 7.69%. The current 10.14% ROE has changed 31.92% with respect to the historical average. Over the past ten years (40 quarters), BOPCF's ROE was at its highest in in the December 2021 quarter at 100.74%. The ROE was at its lowest in in the June 2021 quarter at -94.01%.
Average
7.69%
Median
7.28%
Minimum
2.94%
Maximum
13.63%
Discovering the peaks and valleys of BioPharma Credit PLC ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 118.80%
Maximum Annual ROE = 13.63%
Minimum Annual Increase = -40.66%
Minimum Annual ROE = 2.94%
| Year | ROE | Change |
|---|---|---|
| 2024 | 10.34% | 27.83% |
| 2023 | 8.09% | -40.66% |
| 2022 | 13.63% | 118.80% |
| 2021 | 6.23% | -3.62% |
| 2020 | 6.46% | -25.82% |
| 2019 | 8.71% | 71.44% |
| 2018 | 5.08% | 72.64% |
The current ROE of BioPharma Credit PLC (BOPCF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.69%
5-year avg
8.95%
10-year avg
7.69%
BioPharma Credit PLC’s ROE is less than IntegraFin Holdings plc (23.66%), less than Guardian Capital Group Limited (11.59%), less than Patrizia Se (2.01%), less than Ratos AB (publ) (27.04%), less than Centuria Capital Group (5.97%), greater than Leonteq AG (-0.08%), less than United Corporations Limited (10.58%), less than Insignia Financial Ltd. (0.79%), less than Bolsa Mexicana de Valores, S.A.B. de C.V. (23.41%), less than Laurentian Bank of Canada (5.23%),
| Company | ROE | Market cap |
|---|---|---|
| 23.66% | $908.88M | |
| 11.59% | $1.18B | |
| 2.01% | $976.97M | |
| 27.04% | $1.18B | |
| 5.97% | $996.06M | |
| -0.08% | $889.25M | |
| 10.58% | $1.14B | |
| 0.79% | $868.35M | |
| 23.41% | $1.12B | |
| 5.23% | $1.27B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioPharma Credit PLC using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BioPharma Credit PLC or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BioPharma Credit PLC's ROE?
How is the ROE calculated for BioPharma Credit PLC (BOPCF)?
What is the highest ROE for BioPharma Credit PLC (BOPCF)?
What is the 3-year average ROE for BioPharma Credit PLC (BOPCF)?
What is the 5-year average ROE for BioPharma Credit PLC (BOPCF)?
How does the current ROE for BioPharma Credit PLC (BOPCF) compare to its historical average?